Rovin Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $646K | Sell |
26,662
-1,845
| -6% | -$44.7K | 0.2% | 82 |
|
|
2025
Q1 | $722K | Buy |
28,507
+4,303
| +18% | +$109K | 0.23% | 74 |
|
|
2024
Q4 | $642K | Sell |
24,204
-3,257
| -12% | -$86.4K | 0.23% | 74 |
|
|
2024
Q3 | $795K | Buy |
27,461
+4,139
| +18% | +$120K | 0.29% | 71 |
|
|
2024
Q2 | $653K | Buy |
23,322
+3,652
| +19% | +$102K | 0.27% | 72 |
|
|
2024
Q1 | $546K | Buy |
19,670
+3,862
| +24% | +$107K | 0.22% | 91 |
|
|
2023
Q4 | $455K | Buy |
15,808
+1,477
| +10% | +$42.5K | 0.21% | 93 |
|
|
2023
Q3 | $475K | Buy |
14,331
+5,977
| +72% | +$198K | 0.22% | 62 |
|
|
2023
Q2 | $306K | Buy |
+8,354
| New | +$306K | 0.14% | 105 |
|
|
2022
Q1 | – | Sell |
-10,184
| Closed | -$601K | – | 129 |
|
|
2021
Q4 | $601K | Buy |
+10,184
| New | +$601K | 0.29% | 61 |
|